Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Adamas Announces Topline Phase 1b Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
September 07, 2017 08:30 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced positive topline data from the Phase 1b clinical trial of ADS-4101 (lacosamide)...
Number of People with Epilepsy in the United States at All-time High, CDC Reports
August 10, 2017 13:00 ET
|
Epilepsy Foundation
LANDOVER, Md., Aug. 10, 2017 (GLOBE NEWSWIRE) -- There are more people living with epilepsy in the United States than ever before, according to the new Morbidity and Mortality Weekly Report from the...
Adamas to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8, 2017
August 01, 2017 14:33 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the company will report second quarter 2017 financial results on Tuesday, August...
Earth Science Tech, Inc. Finalizes New KannaBidioiD Product Labels & Updates Shareholders
July 27, 2017 08:25 ET
|
Earth Science Tech, Inc.
Hollywood, July 27, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTCPINK: ETST), an innovative biotech company focused on industrial hemp, cannabinoid research and development,...
Shopko Named as Kick-Off Partner for Lemonade for Livy to Support Local Epilepsy Foundations
June 12, 2017 10:00 ET
|
Epilepsy Foundation
GREEN BAY, Wis., June 12, 2017 (GLOBE NEWSWIRE) -- Epilepsy Foundation’s Lemonade for Livy initiative has named national retail chain, Shopko, its official kick-off partner. Originally established...
Adamas to Present at Two Upcoming Investor Conferences
June 01, 2017 12:31 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that Gregory T. Went, Ph.D., the company’s Chairman and Chief Executive Officer, is...
Epilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products to Help People Living with Seizures
May 31, 2017 11:09 ET
|
Epilepsy Foundation
LANDOVER, Md., May 31, 2017 (GLOBE NEWSWIRE) -- The Epilepsy Foundation announced the winners of the 2017 Shark Tank competition for innovative ideas in epilepsy and seizure treatment and care on...
Adamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in Epilepsy
May 22, 2017 08:30 ET
|
Adamas Pharmaceuticals, Inc.
-- Phase 1 results show ADS-4101 is better tolerated in healthy volunteers than equivalent doses of VIMPAT® (lacosamide) immediate-release tablets -- -- Multi-dose Phase 1b steady state study...
Indoor Harvest Corp Signs Definitive Agreement to Acquire Alamo CBD
April 24, 2017 11:17 ET
|
Indoor Harvest Corp
HOUSTON, April 24, 2017 (GLOBE NEWSWIRE) -- Indoor Harvest Corp (OTCQB:INQD) is pleased to announce, with Alamo CBD, LLC (“Alamo”), that on April 20, 2017 both Companies entered into a definitive...
Epilepsy Foundation announces the second Live Stream ‘Talk About It for Epilepsy!’ Presented by Sunovion event in partnership with actor Greg Grunberg and CBS Local
April 13, 2017 10:03 ET
|
Epilepsy Foundation
LANDOVER, Md., April 13, 2017 (GLOBE NEWSWIRE) -- On May 6, 2017, the Epilepsy Foundation and actor/philanthropist Greg Grunberg will host “Talk About It for Epilepsy” Presented by Sunovion, the...